Mic Lajiness
Mic Lajiness
lilly.com üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Navigating structure–activity landscapes
J Bajorath, L Peltason, M Wawer, R Guha, MS Lajiness, JH Van Drie
Drug discovery today 14 (13-14), 698-705, 2009
1632009
Assessment of the consistency of medicinal chemists in reviewing sets of compounds
MS Lajiness, GM Maggiora, V Shanmugasundaram
Journal of medicinal chemistry 47 (20), 4891-4896, 2004
1422004
Molecular properties that influence oral drug-like behavior
MS Lajiness, M Vieth, J Erickson
Current Opinion in Drug Discovery and Development 7 (4), 470-477, 2004
1242004
Approaches to virtual library design
JH Van Drie, MS Lajiness
Drug Discovery Today 3 (6), 274-283, 1998
1211998
Dissimilarity-based compound selection techniques
MS Lajiness
Perspectives in drug discovery and design 7 (1), 65-84, 1996
991996
Age-related changes in the immune system of mice of eight medium and long-lived strains and hybrids. I. Organ, cellular, and activity changes
MMB Kay, J Mendoza, J Diven, T Denton, N Union, M Lajiness
Mechanisms of ageing and development 11 (5-6), 295-346, 1979
911979
Systems chemical biology and the Semantic Web: what they mean for the future of drug discovery research
DJ Wild, Y Ding, AP Sheth, L Harland, EM Gifford, MS Lajiness
Drug discovery today 17 (9-10), 469-474, 2012
752012
Molecular similarity-based methods for selecting compounds for screening
MS Lajiness
Computational chemical graph theory, 299-316, 1990
731990
Implementing drug screening programs using molecular similarity methods.
MS Lajiness, MA Johnson, GM Maggiora
Progress in clinical and biological research 291, 173-176, 1989
621989
Hit-directed nearest-neighbor searching
V Shanmugasundaram, GM Maggiora, MS Lajiness
Journal of medicinal chemistry 48 (1), 240-248, 2005
592005
Enhancement of binary QSAR analysis by a GA-based variable selection method
H Gao, MS Lajiness, J Van Drie
Journal of Molecular Graphics and Modelling 20 (4), 259-268, 2002
552002
Molecular similarity: a basis for designing drug screening programs
M Johnson, M Lajiness, G Maggiora
Progress in clinical and biological research 291, 167-171, 1989
551989
Four association coefficients for relating molecular similarity measures
C Cheng, G Maggiora, M Lajiness, M Johnson
Journal of chemical information and computer sciences 36 (4), 909-915, 1996
411996
WENDI: a tool for finding non-obvious relationships between compounds and biological properties, genes, diseases and scholarly publications
Q Zhu, MS Lajiness, Y Ding, DJ Wild
Journal of cheminformatics 2 (1), 1-9, 2010
372010
Evaluation of the performance of dissimilarity selection methodology
M Lajiness
QSAR: Rational approaches to the design of bioactive compounds, 201-204, 1991
361991
Dissimilarity-based approaches to compound acquisition
M Lajiness, I Watson
Current opinion in chemical biology 12 (3), 366-371, 2008
242008
A practical strategy for directed compound acquisition
GM Maggiora, V Shanmugasundaram, MS Lajiness, TN Doman, ...
Chemoinformatics in Drug Discovery, 317-332, 2005
242005
Semantic inference using chemogenomics data for drug discovery
Q Zhu, Y Sun, S Challa, Y Ding, MS Lajiness, DJ Wild
BMC bioinformatics 12 (1), 1-12, 2011
222011
Capturing chemical information in an extended relational database system
TR Hagadone, MS Lajiness
Tetrahedron Computer Methodology 1 (3), 219-230, 1988
131988
Asymmetric similarity and molecular diversity.
GM Maggiora, J Mestres, TR Hagadone, MS Lajiness
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 213, 12-CINF, 1997
81997
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20